Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Julphar
Colorcon
Healthtrust
Deloitte
Federal Trade Commission
QuintilesIMS
Harvard Business School
Cantor Fitzgerald
Mallinckrodt

Generated: January 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 016673

« Back to Dashboard

NDA 016673 describes DEXTROSE 5% IN PLASTIC CONTAINER, which is a drug marketed by Baxter Hlthcare, Icu Medical Inc, Hospira, B Braun, Miles, Abbott, DHL, and Fresenius Kabi Usa, and is included in forty-nine NDAs. It is available from seven suppliers. Additional details are available on the DEXTROSE 5% IN PLASTIC CONTAINER profile page.

The generic ingredient in DEXTROSE 5% IN PLASTIC CONTAINER is dextrose; potassium chloride; sodium chloride. There are eight drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the dextrose; potassium chloride; sodium chloride profile page.
Summary for 016673
Tradename:DEXTROSE 5% IN PLASTIC CONTAINER
Applicant:Baxter Hlthcare
Ingredient:dextrose
Patents:0
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 016673
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DEXTROSE 5% IN PLASTIC CONTAINER dextrose INJECTABLE;INJECTION 016673 NDA Baxter Healthcare Corporation 0338-0017 0338-0017-10 4 BAG in 1 POUCH (0338-0017-10) > 25 mL in 1 BAG
DEXTROSE 5% IN PLASTIC CONTAINER dextrose INJECTABLE;INJECTION 016673 NDA Baxter Healthcare Corporation 0338-0017 0338-0017-03 500 mL in 1 BAG (0338-0017-03)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength5GM/100ML
Approval Date:Approved Prior to Jan 1, 1982TE:APRLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength50MG/ML
Approval Date:Oct 30, 1985TE:APRLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cipla
Farmers Insurance
Chubb
Mallinckrodt
Deloitte
Cerilliant
Baxter
US Army
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot